- £198.21bn
- £217.54bn
- $54.07bn
- 85
- 16
- 86
- 71
REG - JPMorgan Elect PLC JPMorgan Elect-JPEI JPMorgan Elect PLC . - Ten Largest Investments
AnnouncementREG - AstraZeneca PLC - Trastuzumab deruxtecan achieves ORR of 60.9%
AnnouncementREG - AstraZeneca PLC - Lynparza approved in China for 1L BRCAm ovarian
AnnouncementREG - AstraZeneca PLC - AstraZeneca divests Seroquel rights: US and Canada
AnnouncementREG - AstraZeneca PLC - Block listing Interim Review
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Imfinzi granted FDA Priority Review for SCLC
AnnouncementREG - AstraZeneca PLC - Calquence approved in CLL in the US
AnnouncementREG - AstraZeneca PLC - Qtrilmet approved in the EU for treatment of T2D
AnnouncementREG - AstraZeneca PLC - FDA accepts regulatory submission for selumetinib
AnnouncementREG - AstraZeneca PLC - Anifrolumab demonstrated superiority in TULIP 2
AnnouncementREG - AstraZeneca PLC - Roxadustat pooled analyses: no increased CV risk
AnnouncementREG - AstraZeneca PLC - Roxadustat significantly increased haemoglobin
AnnouncementREG - AstraZeneca PLC - Calquence data to show improved progression-free
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - AstraZeneca divests rights to Seroquel and
AnnouncementREG - AstraZeneca PLC - Imfinzi and Imfinzi plus tremelimumab delayed
AnnouncementREG - AstraZeneca PLC - AstraZeneca year-to-date and Q3 2019 results
AnnouncementREG - AstraZeneca PLC - Farxiga approved in the US to reduce the risk of
Announcement